UY34585A - Compuestos b-lactámicos sustituidos con amidina, su preparación y uso - Google Patents

Compuestos b-lactámicos sustituidos con amidina, su preparación y uso

Info

Publication number
UY34585A
UY34585A UY0001034585A UY34585A UY34585A UY 34585 A UY34585 A UY 34585A UY 0001034585 A UY0001034585 A UY 0001034585A UY 34585 A UY34585 A UY 34585A UY 34585 A UY34585 A UY 34585A
Authority
UY
Uruguay
Prior art keywords
lactamic
amidine
preparation
compounds replaced
compounds
Prior art date
Application number
UY0001034585A
Other languages
English (en)
Inventor
Dr Burkhard Klenke
Dr Irith Wiegand
Dr Guido Schiffer
Prof Dr Heike Broetz-Oesterhelt
Dr Samarendra N Maiti
Dr Rahim Mohammad
Dr Andhe Reddy
Dr Zhixiang Yang
Dr Mostafa Hena
Dr Guofeng Jia
Dr Ligong Ou
Dr Hong Liang
Dr Judy Yip
Dr Chuanjun Gao
Dr Sabiha Tajammul
Dr Ganguli Biswajeet
Dr Jehangir Khan
Original Assignee
Aicuris Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aicuris Gmbh & Co Kg filed Critical Aicuris Gmbh & Co Kg
Publication of UY34585A publication Critical patent/UY34585A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

La presente invención se relaciona con compuestos ß-lactámicos novedosos, su preparación y uso. En particular esta invención se relaciona con compuestos ß-lactámicos novedosos que son derivados monbactamicos sustituidos con amidina útiles como agentes antimicrobianos y su preparación
UY0001034585A 2012-01-24 2013-01-22 Compuestos b-lactámicos sustituidos con amidina, su preparación y uso UY34585A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12152279 2012-01-24

Publications (1)

Publication Number Publication Date
UY34585A true UY34585A (es) 2013-09-02

Family

ID=47603723

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034585A UY34585A (es) 2012-01-24 2013-01-22 Compuestos b-lactámicos sustituidos con amidina, su preparación y uso

Country Status (43)

Country Link
US (2) US9556165B2 (es)
EP (1) EP2806873B1 (es)
JP (1) JP5869701B2 (es)
KR (1) KR102036393B1 (es)
CN (1) CN104203237A (es)
AP (1) AP2014007880A0 (es)
AR (1) AR089796A1 (es)
AU (1) AU2013211575B2 (es)
BR (1) BR112014017968A8 (es)
CA (1) CA2862338C (es)
CL (1) CL2014001956A1 (es)
CO (1) CO7101240A2 (es)
CU (1) CU24273B1 (es)
CY (1) CY1117955T1 (es)
DK (1) DK2806873T3 (es)
EA (1) EA027126B1 (es)
EC (1) ECSP14010249A (es)
ES (1) ES2592403T3 (es)
HK (1) HK1203389A1 (es)
HR (1) HRP20161171T1 (es)
HU (1) HUE030452T2 (es)
IL (1) IL233805A (es)
IN (1) IN2014MN01640A (es)
LT (1) LT2806873T (es)
MA (1) MA35905B1 (es)
ME (1) ME02532B (es)
MX (1) MX346602B (es)
MY (1) MY173843A (es)
NZ (1) NZ626951A (es)
PE (1) PE20142345A1 (es)
PH (1) PH12014501671A1 (es)
PL (1) PL2806873T3 (es)
PT (1) PT2806873T (es)
RS (1) RS55210B1 (es)
SG (1) SG11201403930XA (es)
SI (1) SI2806873T1 (es)
SM (1) SMT201600354B (es)
TN (1) TN2014000297A1 (es)
TW (1) TWI659953B (es)
UA (1) UA110880C2 (es)
UY (1) UY34585A (es)
WO (1) WO2013110643A1 (es)
ZA (1) ZA201405057B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160326157A1 (en) * 2014-01-06 2016-11-10 President And Fellows Of Harvard College Monobactams and methods of their synthesis and use
ES2862203T3 (es) 2014-03-24 2021-10-07 Novartis Ag Compuestos orgánicos de monobactam para el tratamiento de infecciones bacterianas
CN105175335B (zh) * 2015-08-13 2017-11-03 南阳师范学院 一种3‑(3,3‑二氯烯丙氧基)‑1‑甲基吡唑‑5‑甲酰胺衍生物及其制备方法
CA2999794C (en) * 2015-09-23 2023-08-15 Novartis Ag Salts and solid forms of monobactam antibiotic
MA44083A (fr) 2015-12-15 2021-06-02 Merck Sharp & Dohme Composés de biarylmonobactame pour le traitement d'infections bactériennes
RU2733402C2 (ru) * 2016-03-07 2020-10-01 Мерк Шарп И Доум Корп. Бициклические арильные монобактамовые соединения и способы их применения для лечения бактериальных инфекций
CN107641119B (zh) 2016-07-21 2019-11-08 中国科学院上海药物研究所 单环β-内酰胺-铁载体轭合物及其制备方法和用途
CN109863162B (zh) 2016-08-26 2023-03-17 科德克希思公司 工程化亚胺还原酶和用于酮和胺化合物的还原胺化的方法
CN110022857A (zh) 2016-11-18 2019-07-16 艾库里斯抗感染治疗有限公司 基于改性环糊精和酸化剂的脒取代β-内酰胺化合物的新制剂、其制备及作为抗微生物药物组合物的用途
CN109982696A (zh) 2016-11-18 2019-07-05 艾库里斯抗感染治疗有限公司 治疗细菌感染用的脒取代β-内酰胺化合物的脂质体制剂
MX2019007613A (es) 2016-12-21 2019-09-04 Aicuris Gmbh & Co Kg Terapia de combinacion con compuestos ?-lactamicos sustituidos con amidina e inhibidores de ?-lactamasa para infecciones con cepas bacterianas resistentes a antibioticos.
RU2020107152A (ru) 2017-07-18 2021-08-27 Байер Кропсайенс Акциенгезельшафт Замещенные 3-гетероарилокси-1н-пиразолы и их соли, а также применение в качестве гербицидных активных веществ
WO2019020810A1 (en) 2017-07-28 2019-01-31 Aicuris Anti-Infective Cures Gmbh CRYSTALLINE FORM OF (2S) -2 - [[(Z) - [- 1- (2-AMINO-4-THIAZOLYL) -2 - [[(3S) -2,2-DIMETHYL-4-OXO] -Acid 1- (SULFOOXY) -3-AZETIDINYL] AMINO] -2-OXOETHYLIDENE] AMINO] OXY] -3- [4- [IMINO [(3R) -3-PIPERIDINYLAMINO] METHYL] PHENOXY] -PROPANOIC
CA3063649A1 (en) 2017-08-02 2019-02-07 Novartis Ag Chemical process for manufacturing monobactam antibiotic and intermediates thereof
CA3077474A1 (en) * 2017-10-02 2019-04-11 Arixa Pharmaceuticals, Inc. Aztreonam derivatives and uses thereof
BR112020006381A8 (pt) * 2017-10-02 2023-04-11 Merck Sharp & Dohme Composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
JP7280273B2 (ja) * 2018-01-29 2023-05-23 メッドシャイン ディスカバリー インコーポレイテッド 細菌感染を治療するための単環β－ラクタム化合物
CA3119394A1 (en) * 2018-11-13 2020-05-22 Nanjing Sanhome Pharmaceutical Co., Ltd. Monobactam compounds and use therefor
EP3901150A4 (en) 2018-12-18 2022-09-07 Medshine Discovery Inc. APPLICATION OF A MONOCYCLIC BETA-LACTAM COMPOUND IN PHARMACY
CN111303144B (zh) * 2019-12-13 2020-11-27 苏州信诺维医药科技有限公司 一种治疗细菌感染的化合物
WO2021121387A1 (zh) 2019-12-19 2021-06-24 南京明德新药研发有限公司 化合物在制药中的应用
CN111253405B (zh) * 2020-03-20 2022-12-16 南京安伦化工科技有限公司 一种比阿培南中间体的制备方法
CN111675641B (zh) * 2020-06-04 2023-09-08 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） 单环β-内酰胺类化合物、单环内酰胺类化合物盐及其制备方法
CN111592536B (zh) * 2020-06-04 2023-11-03 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） 单环β-内酰胺化合物及其制备方法和应用
CN115210231A (zh) * 2020-07-16 2022-10-18 宁夏农林科学院 新型单环内酰胺类化合物、其制备方法及其作为抗菌药的用途
EP4007759A4 (en) * 2020-08-06 2024-04-10 Ningxia Academy Agriculture & Forestry Sciences BETA-LACTAM COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIBACTERIAL AGENTS
CN112079791A (zh) * 2020-08-21 2020-12-15 宁夏农林科学院农业资源与环境研究所（宁夏土壤与植物营养重点实验室） 单环β-内酰胺类抗生素侧链酸及其酯、其制备方法和应用
CN111909067B (zh) * 2020-08-28 2022-03-15 浙江凯普化工有限公司 一种d-青霉胺的有机全合成方法
WO2023082055A1 (zh) * 2021-11-09 2023-05-19 中国医学科学院医药生物技术研究所 包含β-内酰胺类化合物的药物组合物及其用途
WO2023091438A1 (en) 2021-11-18 2023-05-25 Merck Sharp & Dohme Llc Chromane amidine monobactam antibiotics

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE794886A (fr) * 1972-02-22 1973-08-02 Pfizer Acides 6-(alpha-(omega-guanidinoalcanoylamino)acylamino)-penicillaniques
DE2458973A1 (de) * 1974-12-13 1976-06-16 Hoechst Ag Acylaminopenicillansaeuren und verfahren zu ihrer herstellung
DE2749265A1 (de) 1977-11-03 1979-05-10 Linde Ag Verfahren zur biologischen reinigung von abwasser
ZA806977B (en) * 1979-11-19 1981-10-28 Fujisawa Pharmaceutical Co 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
JPS58210061A (ja) * 1982-05-31 1983-12-07 Takeda Chem Ind Ltd １−スルホ−２−オキソアゼチジン誘導体、その製造法および用途
CA1262128A (en) 1981-08-27 1989-10-03 Christian N. Hubschwerlen .beta.-lactams
NZ205642A (en) 1982-10-06 1986-08-08 Squibb & Sons Inc Beta-lactams and pharmaceutical compositions
US4638060A (en) 1985-04-29 1987-01-20 E. R. Squibb & Sons, Inc. O-sulfated spiro β-lactam hydroxamic acids
EP0336667A3 (en) 1988-04-04 1991-04-10 E.R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]-amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
US5112968A (en) 1989-07-28 1992-05-12 E. R. Squibb & Sons, Inc. Monobactam hydrazide derivatives
CA2024282A1 (en) 1989-09-21 1991-03-22 Peter H. Ermann Heterocyclic hydrazide derivatives of monocyclic beta-lactam antibiotics
ZA918014B (en) 1990-11-05 1992-07-29 Squibb & Sons Inc Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
US5250691A (en) 1991-09-09 1993-10-05 E. R. Squibb & Sons, Inc. Heteroaryl derivatives of monocyclic beta-lactam antibiotics
US5994340A (en) 1997-08-29 1999-11-30 Synphar Laboratories, Inc. Azetidinone derivatives as β-lactamase inhibitors
DK1322648T3 (da) * 2000-09-14 2005-10-31 Pantherix Ltd 3-(heteroarylacetamido)-2-oxo-azetidin-1-sulfonsyrederivater som antibakterielle midler
AU2005206229A1 (en) 2004-01-27 2005-08-04 Merck Frosst Company Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors
CA2631096A1 (en) 2005-09-23 2007-03-23 M's Science Corporation Piperidine and piperazine derivatives
CN102988362B (zh) * 2005-12-07 2014-11-05 巴斯利尔药物股份公司 单环-内酰胺类抗生素与β-内酰胺酶抑制剂的有效的联合应用
BRPI0707801B1 (pt) 2006-02-14 2018-01-16 Kumiai Chemical Industry Co., Ltd. Composto de 5-alcóxi-4-hidroximetilpirazol e processo para a produção do referido composto
JP2009530228A (ja) 2006-03-16 2009-08-27 アステラス製薬株式会社 セフェム化合物および抗菌薬としての利用
AU2008231854B2 (en) 2007-03-23 2013-03-21 Basilea Pharmaceutica Ag Combination medicaments for treating bacterial infections
WO2009049028A1 (en) 2007-10-09 2009-04-16 Targegen Inc. Pyrrolopyrimidine compounds and their use as janus kinase modulators
KR20110086742A (ko) 2008-12-19 2011-07-29 화이자 인코포레이티드 모노카밤

Also Published As

Publication number Publication date
TN2014000297A1 (en) 2015-12-21
EA027126B1 (ru) 2017-06-30
LT2806873T (lt) 2016-10-10
US20150045340A1 (en) 2015-02-12
CN104203237A (zh) 2014-12-10
CO7101240A2 (es) 2014-10-31
AU2013211575A1 (en) 2014-07-24
ES2592403T3 (es) 2016-11-30
PH12014501671B1 (en) 2014-11-10
KR102036393B1 (ko) 2019-10-24
SG11201403930XA (en) 2014-08-28
IL233805A0 (en) 2014-09-30
CL2014001956A1 (es) 2014-11-07
AU2013211575B2 (en) 2017-03-02
UA110880C2 (uk) 2016-02-25
HRP20161171T1 (hr) 2016-11-04
HK1203389A1 (zh) 2015-10-30
EP2806873A1 (en) 2014-12-03
BR112014017968A2 (es) 2017-06-20
AP2014007880A0 (en) 2014-08-31
PL2806873T3 (pl) 2016-12-30
BR112014017968A8 (pt) 2017-07-11
PT2806873T (pt) 2016-09-23
WO2013110643A1 (en) 2013-08-01
ZA201405057B (en) 2017-09-27
RS55210B1 (sr) 2017-01-31
SMT201600354B (it) 2016-11-10
JP2015504907A (ja) 2015-02-16
HUE030452T2 (en) 2017-05-29
EA201400838A1 (ru) 2014-12-30
IL233805A (en) 2016-06-30
ME02532B (me) 2017-02-20
MX346602B (es) 2017-03-24
DK2806873T3 (en) 2016-08-29
TW201343643A (zh) 2013-11-01
CU24273B1 (es) 2017-08-08
CA2862338A1 (en) 2013-08-01
IN2014MN01640A (es) 2015-05-22
EP2806873B1 (en) 2016-06-15
CY1117955T1 (el) 2017-05-17
PH12014501671A1 (en) 2014-11-10
CA2862338C (en) 2019-04-16
CU20140090A7 (es) 2014-12-26
JP5869701B2 (ja) 2016-02-24
NZ626951A (en) 2016-03-31
US20170100379A1 (en) 2017-04-13
MY173843A (en) 2020-02-24
US9782390B2 (en) 2017-10-10
SI2806873T1 (sl) 2016-10-28
MA35905B1 (fr) 2014-12-01
MX2014008915A (es) 2014-08-26
US9556165B2 (en) 2017-01-31
TWI659953B (zh) 2019-05-21
ECSP14010249A (es) 2015-12-31
AR089796A1 (es) 2014-09-17
PE20142345A1 (es) 2015-01-09
KR20140114390A (ko) 2014-09-26

Similar Documents

Publication Publication Date Title
UY34585A (es) Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
DOP2017000078A (es) Indazoles sustituidos con bencilo como inhibidores de bub1.
UY34632A (es) Compuestos de oxazolidin- 2- ona y usos de los mismos
UY34797A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
UY34765A (es) Compuestos novedosos.
UY34591A (es) Compuestos de imidazopirrolidinona
UY34824A (es) Nucleósidos de espirooxetano de uracilo
UY34566A (es) 1,4?dihidropirimidinas 4,4?disustituidas y su uso como medicamentos para el tratamiento de la hepatitis b
UY34778A (es) ?COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2-AMINA HETEROCÍCLICOS SUSTITUÍDOS?.
PH12016500676A1 (en) Pyrimidine fgfr4 inhibitors
UY34817A (es) Tienopirimidinas
UY34820A (es) Compuestos tipo pirrolo-pirrolidinona
UY34302A (es) COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2- AMINA
UY34763A (es) Inhibidores de la agregación plaquetaria
UY34536A (es) Nucleósidos sustituidos, nucleótidos y análogos de los mismos
UY34697A (es) Métodos para preparar análogos de nucleótidos
UY34200A (es) 3-(fluorovinil)pirazoles y su uso
UY34342A (es) ?derivados de pirrolopirimidina y purina?.
UY34844A (es) Formas sólidas de un compuesto antiviral
UY34515A (es) Triazolopiridinas sustituidas
UY34767A (es) Inhibidores cíclicos del enlace éter de dgat1
UY34863A (es) Antagonistas de iap
UY34610A (es) Pirroldicarboxamidas condensadas y su uso como agentes farmacéuticos.
UY34590A (es) Fenilimidazopirazoles sustituidos y su uso
UY34469A (es) Composicion herbicida

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20210526